BIOBITS: A study on candidatus glomeribacter gigasporarum with a data warehouse

Francesca Cordero, Stefano Ghignone, Luisa Lanfranco, Giorgio Leonardi, Rosa Meo, Luca Roversi

Risultato della ricerca: Capitolo in libro/report/atti di convegnoContributo in volume (Capitolo o Saggio)peer review

Abstract

Biotech is effectively changing the way the largest chemical companies do business, in which as demonstrated by pharmaceutical industries, DNA is used to create novel therapeutics. A crucial advance in this direction is coming from Metagenomics, the emerging science branch that has the potential to substantially impact industrial production, as shown by the company founded by Venter http://www.tigr.org/. Industries have different motivations to probe the enormous resource represented by uncultivated microbial diversity. Currently, there is a global political drive to promote biotechnologies as a central feature of the sustainable economic future of modern industrialized societies.

Lingua originaleInglese
Titolo della pubblicazione ospiteDatabase Technology For Life Sciences And Medicine
EditoreWorld Scientific Publishing Co.
Pagine139-155
Numero di pagine17
ISBN (elettronico)9789814307710
Stato di pubblicazionePubblicato - 1 gen 2010
Pubblicato esternamente

Fingerprint

Entra nei temi di ricerca di 'BIOBITS: A study on candidatus glomeribacter gigasporarum with a data warehouse'. Insieme formano una fingerprint unica.

Cita questo